Advisory Committees

Roster of the Transmissible Spongiform Encephalopathies Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 4
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

  • TSEAC Chair: Vacant
    Bryan Emery, LCDR, R.N.

    Center for Biologics Evaluation and Research
    1401 Rockville Pike (HFM-71)
    Food and Drug Administration
    Rockville, Maryland 20852-1448
    TEL: (301) 827-1277
    FAX: (301) 827-0294
  • Ermias D. Belay, M.D.
    Expertise: Medical Epidemiology
    Term: 08/09/12 – 01/31/2016

    Associate Director for Epidemiologic Science
    Division of High – Consequence Pathogens and Pathology
    National Center for Emerging and Zoonotic Infectious Diseases
    Centers For Disease Control and Prevention
    Division of Viral & Ricketsial Diseases
    1600 Clifton Road
    Mailstop A-30
    Atlanta, Georgia 30333
  • Byron Caughey, Ph.D.
    Expertise: Prion Biochemistry
    Term: 06/04/2013-01/31/2016

    Senior Investigator
    Chief, TSE/prion Biochemistry Section
    Laboratory of Persistent Viral Diseases
    NIH/NIAID Rocky Mountain Laboratories
    903 S 4th St.
    Hamilton, MT 59840 USA
  • Bernardino Ghetti, M.D.
    Expertise: Neuropathology
    Term: 02/01/15 – 01/31/2019

    Distinguished Professor
    Indiana University School of Medicine
    Division of Neuropathology
    635 Barnhill Drive, A138
    Indianapolis, IN 46202-5120
  • Dean E. Goeldner, D.V.M.
    Expertise: Veterinary Medicine/BSE
    Term: 08/09/12 – 01/31/2016

    Senior Staff Veterinarian
    USDA/APHIS Veterinary Services
    4700 River Road, Unit 43
    Riverdale, MD 20737
  • David M. Huskie, R. N.
    Expertise: Consumer Advocate
    Term: 08/09/2012-01/31/2016

    Orthopedic Nurse
    Veterans Affairs Medical Center
    113 Holland Avenue
    Albany, New York 12138-0235
  • Richard J. Kascsak, Ph.D.
    Expertise: Prion Tissues/ Mab
    Term: 07/03/2013-01/31/2017

    Head, IBR Monoclonal Antibody Facility
    NY State Institute for Basic Research
    1050 Forest Hill Road
    Staten island, NY 10314
  • Florence Kranitz*
    Expertise: Consumer Representative
    Term: 05/11/2012-01/31/2016

    The CJD Foundation
    3632 W. Market Street, Suite 105 N
    Akron, Ohio 44333
  • Sivan Leviyang, Ph.D.
    Expertise: Modeling
    Term: 08/25/2013-01/31/2017

    Assistant Professor
    Department of Mathematics
    Georgetown University
    St. Mary's Building
    Washington DC 20057
  • Raymond P. Roos, M.D.
    Expertise: Neuropsychiatry
    Term: 11/24/14--01/31/18

    Marjorie & Robert E. Straus Professor in Neurological Science
    Department of Neurology
    University of Chicago
    5841 South Maryland Avenue, MC 2030
    Chicago, IL 60637
  • Jiri G. Safar, M.D.
    Expertise: Prion Neurology
    Term: 11/24/14--01/31/18

    Associate Professor, Departments of Pathology and Neurology
    Co-Director, National Prion Disease Pathology Surveillance Center
    Case Western Reserve University
    Institute of Pathology Building, Room 406
    2085 Adelbert Road
    Cleveland, Ohio 44106-4907
  • Christina Sigurdson, DVM, PhD
    Expertise: Veterinary Medicine/ prions
    Term: 08/25/2013-01/31/2017

    Associate Professor
    Department of Pathology
    University of California, San Diego
    9500 Gilman Drive, UC303, Rm 101
    La Jolla, CA 92093-0612
  • Nga Tran, Dr.P.H., M.P.H., C.I.H.
    Expertise: Risks Analysis/ Biostatistics
    Term: 08/25/2013-01/31/2017

    Principal Scientist
    Exponent®, Inc
    1150 Connecticut Avenue NW, Suite 1100
    Washington, DC 20036
    Douglas C. Lee, Ph.D. **
    Expertise: Industry Representative
    Term: 04/15/2009 – 01/31/2017

    Senior VP Plasma Product Development
    CSL Behring AG
    Wankdorfstrasse 10
    CH-3000 Bern 22, Switzerland

* Consumer Representative
** Industry Representative

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 03/23/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.